marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2022
added 03-29-2023
Chembio Diagnostics Balance Sheet 2011-2024 | CEMI
Annual Balance Sheet Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-17.2 M | -27.7 M | -4.7 M | -447 K | -12.1 M | -3.69 M | -10.6 M | -5.38 M | -4.61 M | -9.65 M | -2.82 M | -2.82 M |
Long Term Debt |
76.7 K | 140 K | 18.2 M | 17.6 M | 172 K | 99.5 K | - | - | - | - | 82.2 K | 133 K |
Long Term Debt Current |
915 K | 886 K | 642 K | 568 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 24.8 M | 25.3 M | 1.06 M | 441 K | - | - | - | - | 82.2 K | 133 K |
Total Current Liabilities |
39.3 M | 15.3 M | 12.4 M | 6.44 M | 6.52 M | 3.1 M | 3.41 M | 3.15 M | 5.29 M | 4.31 M | 3.38 M | 2.86 M |
Total Liabilities |
44.8 M | 39 M | 37.1 M | 31.7 M | 7.58 M | 3.54 M | 3.41 M | 3.15 M | 5.29 M | 4.31 M | 3.46 M | 2.99 M |
Deferred Revenue |
- | - | 1.61 M | 125 K | 423 K | 50 K | 393 K | 353 K | 340 K | - | 23.2 K | - |
Retained Earnings |
-154 M | -131 M | -97.1 M | -71.6 M | -57.9 M | -50 M | -43.7 M | -30.3 M | -27.9 M | -26.8 M | -27.3 M | -28.3 M |
Total Assets |
62.6 M | 73.3 M | 64.9 M | 55.7 M | 40.9 M | 16.6 M | 20.6 M | 20.8 M | 25 M | 24.5 M | 17.3 M | 15.5 M |
Cash and Cash Equivalents |
18.2 M | 28.8 M | 23.1 M | 18.3 M | 12.5 M | 3.79 M | 10.6 M | 5.38 M | 4.61 M | 9.65 M | 2.95 M | 3.01 M |
Book Value |
17.8 M | 34.3 M | 27.8 M | 24 M | 33.3 M | 13.1 M | 17.2 M | 17.7 M | 19.7 M | 20.2 M | 13.9 M | 12.5 M |
Total Shareholders Equity |
17.8 M | 34.3 M | 27.8 M | 24 M | 33.3 M | 13.1 M | 17.2 M | 17.7 M | 19.7 M | 20.2 M | 13.9 M | 12.5 M |
All numbers in USD currency
Quarterly Balance Sheet Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 96.5 K | - | 135 K | 140 K | 157 K | 174 K | 170 K | 185 K | 185 K | 185 K | 185 K | 172 K | 17.5 M | 172 K | 172 K | 172 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 95.3 K | 108 K | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 44.4 M | - | 36.4 M | 39 M | 36.1 M | 34.5 M | 34.1 M | 37.1 M | 37.1 M | 37.1 M | 37.1 M | 31.7 M | 31.7 M | 31.7 M | 31.7 M | 7.58 M | 7.58 M | 7.58 M | 7.58 M | 3.54 M | 3.54 M | 3.54 M | 3.54 M | 3.41 M | 3.41 M | 3.41 M | 3.41 M | 3.15 M | 3.15 M | 3.15 M | 3.15 M | 5.29 M | 5.29 M | 5.29 M | 5.29 M | 4.31 M | 4.31 M | 4.31 M | 4.31 M | 3.46 M | 3.46 M | 3.46 M | 3.46 M | 2.99 M | 2.99 M | 2.99 M | 2.99 M |
Deferred Revenue |
- | - | - | - | - | 20.2 K | 400 K | 400 K | 1.61 M | 1.61 M | 1.61 M | 1.61 M | 125 K | 125 K | 125 K | 125 K | 423 K | 423 K | 423 K | 423 K | 50 K | - | 161 K | 117 K | 393 K | 393 K | 393 K | 393 K | 353 K | 353 K | 353 K | 353 K | 340 K | 340 K | 340 K | 340 K | - | - | - | - | - | - | - | - | - | 491 K | - | - |
Retained Earnings |
- | -153 M | - | -140 M | -131 M | -117 M | -111 M | -102 M | -97.1 M | -97.1 M | -97.1 M | -97.1 M | -71.6 M | -71.6 M | -71.6 M | -71.6 M | -57.9 M | -57.9 M | -57.9 M | -57.9 M | -50 M | -50 M | -50 M | -50 M | -43.7 M | -43.7 M | -43.7 M | -43.7 M | -30.3 M | -30.3 M | -30.3 M | -30.3 M | -27.9 M | -27.9 M | -27.9 M | -27.9 M | -26.8 M | -26.8 M | -26.8 M | -26.8 M | -27.3 M | -27.3 M | -27.3 M | -27.3 M | -28.3 M | -28.3 M | -28.3 M | -28.3 M |
Total Assets |
- | 62.2 M | - | 62.9 M | 73.3 M | 84 M | 49.6 M | 57.4 M | 64.9 M | 64.9 M | 64.9 M | 64.9 M | 55.7 M | 55.7 M | 55.7 M | 55.7 M | 40.9 M | 40.9 M | 40.9 M | 40.9 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 20.8 M | 20.8 M | 20.8 M | 20.8 M | 25 M | 25 M | 25 M | 25 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M |
Cash and Cash Equivalents |
- | 21.1 M | - | 24.4 M | 28.8 M | 36 M | 5.56 M | 14.4 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 3.79 M | 3.79 M | 3.79 M | 3.79 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 5.38 M | 5.38 M | 5.38 M | 5.38 M | 4.61 M | 4.61 M | 4.61 M | 4.61 M | 9.65 M | 9.65 M | 9.65 M | 9.65 M | 2.95 M | 2.95 M | 2.95 M | 2.95 M | 3.01 M | 3.01 M | 3.01 M | 3.01 M |
Book Value |
- | 17.8 M | - | 26.5 M | 34.3 M | 47.9 M | 15.1 M | 23.3 M | 27.8 M | 27.8 M | 27.8 M | 27.8 M | 24 M | 24 M | 24 M | 24 M | 33.3 M | 33.3 M | 33.3 M | 33.3 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M |
Total Shareholders Equity |
- | 17.8 M | 19.9 M | 26.5 M | 34.3 M | 47.9 M | 15.1 M | 23.3 M | 27.8 M | 27.8 M | 27.8 M | 27.8 M | 24 M | 24 M | 24 M | 24 M | 33.3 M | 33.3 M | 33.3 M | 33.3 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M |
All numbers in USD currency